Personalized T cell-mediated cancer immunotherapy: progress and challenges.

Michael T Bethune & Alok V Joglekar (2017) Curr Opin Biotechnol. 48, 142-152

Immunotherapies are yielding effective treatments for several previously untreatable cancers. Until recently, vaccines and adoptive cell therapies have been designed to target public tumor antigens common to multiple patients…

View Publication